Cowen Financial Products LLC - Jun 30, 2025 SCHEDULE 13G/A Report for UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN)

Filing Manager: Cowen Financial Products LLC
Reporting Manager: Cowen Financial Products LLC
Security: UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share
Symbol: URGN
Shares outstanding: 46.2M shares
Disclosed Ownership: 3.19M shares
Ownership: 6.9%
Form type: SCHEDULE 13G/A
Date filed: 7/29/2025, 04:56 PM
Date of event: Jun 30, 2025
Previous filing: Jun 13, 2025
Next filing: Nov 14, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Cowen Financial Products LLC	6.9%	3.19M	3.19M	0	John Holmes	John Holmes / Chief Operating Officer